Truist Securities Starts PTC Therapeutics (PTCT) at Hold
Truist Securities analyst Danielle Brill initiates coverage on PTC Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

